A Facile and Convenient Route to 3,4-Disubstituted Quinolin-2(1H)-ones
FULL PAPERS
13C NMR (100 MHz, CDCl3): d=162.2, 150.6, 144.6, 138.9,
137.7, 133.3, 131.3, 120.5, 129.2, 128.6, 128.3, 127.6, 125.4,
125.2, 122.5, 117.8, 113.8, 30.2, 21.6, 21.3; MS: m/z (M+ +
1)=420, calcd.: 420; HR-MS: m/z=419.1195, calcd. for
C24H21NO4S: 419.1191.
1-Methyl-2-oxo-3-(4-(trifluoromethyl)phenyl)-1,2-dihydro-
quinolin-4-yl 4-methylbenzenesulfonate (3e): 1H NMR
(400 MHz, CDCl3): d=8.21 (d, J=8.3 Hz, 1H), 7.69 (t, J=
7.3 Hz, 1H), 7.46–7.24 (m, 9H), 7.03 (d, J=8.3 Hz, 2H),
3.77 (s, 3H), 2.38 (s, 3H); 13C NMR (100 MHz, CDCl3): d=
161.6, 151.4, 145.4, 139.3, 135.5, 133.0, 132.0, 131.2, 129.5,
129.4, 127.4, 125.7, 124.4, 123.6, 122.8, 117.5, 114.0, 30.3,
21.4; MS: m/z (M+ +1)=474, calcd.: 474; HR-MS: m/z=
473.0906, calcd. for C24H18F3NO4S: 473.0909.
1-Methyl-2-oxo-3-(3-(trifluoromethyl)phenyl)-1,2-dihydro-
quinolin-4-yl 4-methylbenzenesulfonate (3f): 1H NMR
(400 MHz, CDCl3): d=8.16 (d, J=7.8 Hz, 1H), 7.68 (t, J=
7.3 Hz, 1H), 7.44 (d, J=8.3 Hz, 1H), 7.38 (t, J=7.3 Hz,
1H), 7.30 (d, J=8.3 Hz, 2H), 7.22–7.16 (m, 2H), 7.08–7.03
(m, 4H), 3.77 (s, 3H), 2.39 (s, 3H); 13C NMR (100 MHz,
CDCl3): d=161.6, 151.1, 148.5, 145.4, 139.2, 133.6, 132.9,
131.9, 129.5, 129.3, 128.8, 127.5, 125.8, 123.5, 123.4, 122.7,
121.6, 116.4, 114.0, 30.3, 21.5; MS: m/z (M+ +1)=474,
(127 mg, 0.60 mmol) was stirred in t-BuOH (2 mL) under ni-
trogen at 808C. The reaction mixture was stirred overnight.
Following completion of the reaction as monitored by TLC,
the reaction mixture was diluted with ethyl acetate (20 mL)
and separated. The solution was dried and filtered, and the
filtrate was concentrated to a residue which was purified by
flash chromatography [silica gel, 2/1 (v/v) hexane/ethyl ace-
tate] to give the corresponding product 4 or 5.
4-(4-Methoxyphenyl)-1-methyl-3-phenylquinolin-2(1H)-
1
one (4a): H NMR (400 MHz, CDCl3): d=7.55 (t, J=7.3 Hz,
1H), 7.43 (d, J=8.8 Hz, 1H), 7.35 (d, J=8.3 Hz, 1H), 7.20–
6.09 (m, 6H), 7.01 (d, J=8.7 Hz, 2H), 6.78 (d, J=8.8 Hz,
2H), 3.82 (s, 3H), 3.76 (s, 3H); 13C NMR (100 MHz,
CDCl3): d=161.8, 158.8, 147.4, 139.5, 136.1, 132.1, 131.1,
130.6, 130.1, 128.4, 127.4, 126.7, 121.7, 113.9, 113.3, 55.1,
30.0; MS: m/z (M+ +1)=342, calcd.: 342; HR-MS: m/z=
341.1419, calcd. for C23H19NO2: 341.1416.
1-Methyl-3,4-diphenylquinolin-2(1H)-one (4b): 1H NMR
(400 MHz, CDCl3): d=7.57 (t, J=7.3 Hz, 1H), 7.45 (d, J=
8.3 Hz, 1H), 7.31–7.23 (m, 4H), 7.16–7.08 (m, 8H), 3.85 (s,
3H); 13C NMR (100 MHz, CDCl3): d=161.8, 147.7, 139.4,
136.2, 135.8, 131.9, 130.5, 130.2, 129.8, 128.4, 127.9, 127.4,
126.8, 121.8, 121.4, 114.0, 30.0; MS: m/z (M+ +1)=312,
calcd.: 312; HR-MS: m/z=311.1312, calcd. for C22H17NO:
311.1310.
calcd.:
474;
HR-MS:
m/z=473.0905,
calcd.
for
C24H18F3NO4S: 473.0909.
3-(4-Cyanophenyl)-1-methyl-2-oxo-1,2-dihydroquinolin-4-
yl 4-methylbenzenesulfonate (3g): 1H NMR (400 MHz,
CDCl3): d=8.14 (d, J=7.8 Hz, 1H), 7.70 (t, J=7.3 Hz, 1H),
7.45 (d, J=8.3 Hz, 1H), 7.41–7.34 (m, 5H), 7.31 (d, J=
8.2 Hz, 2H), 7.13 (d, J=8.3 Hz, 2H), 3.78 (s, 3H), 2.48 (s,
3H); 13C NMR (100 MHz, CDCl3): d=161.3, 151.6, 145.8,
139.4, 136.8, 133.6, 132.3, 131.7, 131.1, 129.6, 127.5, 125.7,
123.2, 122.9, 118.5, 117.4, 114.1, 111.4, 30.3, 21.6; MS: m/z
(M+ +1)=431, calcd.: 431; HR-MS: m/z=430.0982, calcd.
for C24H18N2O4S: 430.0987.
3-(3-Cyanophenyl)-1-methyl-2-oxo-1,2-dihydroquinolin-4-
yl 4-methylbenzenesulfonate (3h): 1H NMR (400 MHz,
CDCl3): d=8.14 (d, J=7.8 Hz, 1H), 7.70 (t, J=7.3 Hz, 1H),
7.61 (d, J=7.8 Hz, 1H), 7.46–7.31 (m, 9H), 7.13 (d, J=
7.8 Hz, 1H), 3.77 (s, 3H), 2.46 (s, 3H); 13C NMR (100 MHz,
CDCl3): d=161.4, 151.4, 145.8, 139.3, 135.4, 134.3, 133.2,
133.0, 132.2, 131.1, 129.8, 128.3, 127.5, 125.8, 122.9, 122.7,
118.2, 117.3, 114.0, 112.0, 29.6, 21.6; MS: m/z (M+ +1)=431,
calcd.: 431; HR-MS: m/z=430.0984, calcd. for C24H18N2O4S:
430.0987.
3-(4-Acetylphenyl)-1-methyl-2-oxo-1,2-dihydroquinolin-4-
yl 4-methylbenzenesulfonate (3i): 1H NMR (400 MHz,
CDCl3): d=8.17 (d, J=8.2 Hz, 1H), 7.81 (d, J=7.8 Hz, 1H),
7.72–7.66 (m, 2H), 7.58 (d, J=7.3 Hz,1H), 7.45 (d, J=
8.8 Hz, 1H), 7.40–7.23 (m, 4H), 7.00 (d, J=8.3 Hz,2H), 3.78
(s, 3H), 2.45 (s, 3H), 2.35 (s, 3H); 13C NMR (100 MHz,
CDCl3): d=197.1, 161.8, 151.2, 145.2, 139.2, 136.5, 135.7,
133.2, 131.9, 131.1, 129.5, 128.0, 127.4, 125.6, 124.0, 122.8,
117.5, 114.0, 30.3, 26.4, 21.5; MS: m/z (M+ +1)=448, calcd.:
448; HR-MS: m/z=447.1138, calcd. for C25H21NO5S:
447.1140.
1-Methyl-3-phenyl-4-(4-(trifluoromethyl)phenyl)quinolin-
2(1H)-one (4c): H NMR (400 MHz, CDCl3): d=7.59 (t, J=
1
8.3 Hz, 1H), 7.53 (d, J=7.8 Hz, 2H), 7.46 (d, J=8.8 Hz,
1H), 7.24 (d, J=7.8 Hz, 2H), 7.19–7.14 (m, 5H), 7.09–7.06
(m, 2H), 3.85 (s, 3H); 13C NMR (100 MHz, CDCl3): d=
161.5, 146.1, 140.2, 139.5, 135.3, 132.3, 130.5, 130.4, 130.3,
127.9, 127.6, 127.2, 125.0, 124.4, 122.5, 122.0, 120.8, 114.2,
30.1; MS: m/z (M+ +1)=380, calcd.: 380; HR-MS: m/z=
379.1180, calcd. for C23H16F3NO: 379.1184.
1-Methyl-3-phenyl-4-(3-(trifluoromethyl)phenyl)quinolin-
2(1H)-one (4d):[22] 1H NMR (400 MHz, CDCl3): d=7.59 (t,
J=7.3 Hz, 1H), 7.47 (d, J=8.3 Hz, 1H), 7.30 (t, J=8.3 Hz,
1H), 7.26 (d, J=8.3 Hz, 1H), 7.17–7.05 (m, 8H), 6.99 (s,
1H), 3.85 (s, 3H); MS m/z (M+ +1)=380, calcd. for
[C23H16F3NO]: 380.
3-(3-Methoxyphenyl)-1-methyl-4-(3-(trifluoromethyl)phe-
nyl)quinolin-2(1H)-one (4e):[22] 1H NMR (400 MHz, CDCl3):
d=7.85 (t, J=7.3 Hz, 1H), 7.45 (d, J=8.3 Hz, 1H), 7.32 (t,
J=8.3 Hz, 1H), 7.26–7.11 (m, 3H), 7.06 (d, J=8.8 Hz, 1H),
7.01–6.98 (m, 3H), 6.71 (d, J=8.8 Hz, 1H), 3.84 (s, 3H),
3.73 (s, 3H); 13C NMR (125 MHz, CDCl3): d=162.0, 158.8,
146.1, 139.8, 137.7, 133.5, 132.6, 132.0, 130.7, 128.9, 128.1,
127.8, 127.2, 127.1, 124.6, 124.5, 122.4, 121.2, 114.5, 113.5,
55.4, 30.4; MS m/z (M+ +1)=410, calcd. for [C24H18F3NO2]:
410.
1-Methyl-3,4-bis(3-(trifluoromethyl)phenyl)quinolin-
2(1H)-one (4f):[22] 1H NMR (400 MHz, CDCl3): d=7.62 (t,
J=7.3 Hz, 1H), 7.48 (d, J=8.3 Hz, 1H), 7.34 (t, J=8.3 Hz,
1H), 7.30–6.99 (m, 7H), 6.95 (s, 1H), 6.88 (s, 1H), 3.85 (s,
3H); 13C NMR (125 MHz, CDCl3): d=161.4, 147.2, 140.0,
136.9, 136.4, 134.2, 133.3, 131.4, 131.2, 130.9, 130.5, 130.2,
129.1, 128.3, 127.8, 127.0, 125.0, 124.2, 122.7, 120.9, 114.7,
30.5; MS: m/z (M+ +1)=448, calcd. for [C24H15F6NO]: 448.
3,4-Bis(4-methoxyphenyl)-1-methylquinolin-2(1H)-one
(5a):[22] 1H NMR (400 MHz, CDCl3): d=7.55 (t, J=8.3 Hz,
1H), 7.43 (d, J=8.3 Hz, 1H), 7.35 (d, J=7.8 Hz, 1H), 7.12
(t, J=7.3 Hz, 1H), 7.04–7.01 (m, 4H), 6.81 (d, J=8.8 Hz,
General Procedure for Synthesis of 3,4-Disubstituted
Quinolin-2(1H)-one 4 or5
A mixture of 3 (0.20 mmol), Pd (OAc)2 (2.2 mg, 0.01 mmol),
ligand A (2.5 mg, 0.02 mmol), arylboronic acid, and K3PO4
Adv. Synth. Catal. 2007, 349, 1943 – 1948
ꢁ 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1947